Drug Chatter -- Tracking biopharma stock chatter

Profile for Aldeyra Therapeutics, Inc. (ALDX)

« Back to company index

ALDX Chatter Timeline

Stock Ticker for ALDX

Most Active Tweeters for ALDX

UserTweets
@dispatchtribune 5
@AmericanBanking 4
@CFinancialNews 3
@intercooleronli 3
@ConsumerFeed 3

Recent Tweets for ALDX

noritsunagirota @noritsunagirota
Aldeyra Therapeutics $ALDX At $6.20 Forms Bottom https://t.co/8kENNJfUbi
November 16th 2017, 6:11am
TheMarketsDaily @TheMarketsDaily
Cantor Fitzgerald Equities Analysts Decrease Earnings Estimates for Aldeyra Therapeutics, Inc. $ALDX https://t.co/fjvEepQ8h7
November 16th 2017, 4:11am
SleekMoneycom @SleekMoneycom
Epizyme $EPZM vs. Aldeyra Therapeutics $ALDX Critical Survey https://t.co/jTGPIXUgFV
November 15th 2017, 9:11pm
IRAMarketReport @IRAMarketReport
Aldeyra Therapeutics, Inc. $ALDX Upgraded to Buy at Zacks Investment Research https://t.co/PWDQ22hURf
November 15th 2017, 6:11pm
WeekHerald @WeekHerald
Aldeyra Therapeutics, Inc. $ALDX Upgraded to Buy at Zacks Investment Research https://t.co/rzq1rOc5fJ
November 15th 2017, 6:11pm
chaffeybreeze @chaffeybreeze
Aldeyra Therapeutics, Inc. $ALDX Upgraded to Buy at Zacks Investment Research https://t.co/FyylZ3PQEx
November 15th 2017, 6:11pm
AlertTrade @AlertTrade
TREND REVERSAL UP ALERT: $ALDX ALDEYRA THERAPEUTICS ? TradeIdeas via https://t.co/VS8RO1bzXJ to Free Trading Room
November 15th 2017, 4:11pm
WatchlistN @WatchlistN
FY2017 Earnings Estimate for Aldeyra Therapeutics, Inc. $ALDX Issued By Cantor Fitzgerald https://t.co/835r60e23m
November 15th 2017, 7:11am
intercooleronli @intercooleronli
FY2017 Earnings Estimate for Aldeyra Therapeutics, Inc. $ALDX Issued By Cantor Fitzgerald https://t.co/rDxQAbS8br
November 15th 2017, 7:11am
CFinancialNews @CFinancialNews
FY2017 Earnings Estimate for Aldeyra Therapeutics, Inc. $ALDX Issued By Cantor Fitzgerald https://t.co/QvMACQEnr9
November 15th 2017, 7:11am
intercooleronli @intercooleronli
Aldeyra Therapeutics, Inc. $ALDX Stock Rating Upgraded by Zacks Investment Research https://t.co/bwdO20OTul
November 14th 2017, 8:11pm
AmericanBanking @AmericanBanking
Aldeyra Therapeutics, Inc. $ALDX Stock Rating Upgraded by Zacks Investment Research https://t.co/e4exVa8RGK
November 14th 2017, 8:11pm
ConsumerFeed @ConsumerFeed
Aldeyra Therapeutics, Inc. $ALDX Stock Rating Upgraded by Zacks Investment Research https://t.co/hMmv8U1TlW #acn
November 14th 2017, 8:11pm
CFinancialNews @CFinancialNews
Aldeyra Therapeutics, Inc. $ALDX Stock Rating Upgraded by Zacks Investment Research https://t.co/8N1emV9rB6
November 14th 2017, 8:11pm
dispatchtribune @dispatchtribune
Aldeyra Therapeutics, Inc. $ALDX Upgraded at Zacks Investment Research https://t.co/pKJSSp3PxR
November 14th 2017, 7:11pm
ConsumerFeed @ConsumerFeed
Aldeyra Therapeutics upgraded by Zacks Investment Research to buy. $6.75 PT. https://t.co/5etEcx0FpI $ALDX #ALDX
November 14th 2017, 7:11pm
RatingsNetwork @RatingsNetwork
Aldeyra Therapeutics upgraded by Zacks Investment Research to buy. $6.75 PT. https://t.co/gzHgzhwa02 $ALDX #ALDX
November 14th 2017, 7:11pm
AmericanBanking @AmericanBanking
Aldeyra Therapeutics upgraded by Zacks Investment Research to buy. $6.75 PT. https://t.co/m2c1JfI4zr $ALDX #ALDX
November 14th 2017, 7:11pm
TickerReport @TickerReport
Aldeyra Therapeutics $ALDX Earns Daily News Sentiment Rating of 0.17 https://t.co/YjB3UVIyxf
November 14th 2017, 4:11pm
emq_news @emq_news
Aldeyra Therapeutics $ALDX Earns Daily News Sentiment Rating of 0.17 https://t.co/l5XPnn67Pw
November 14th 2017, 4:11pm
TickerReport @TickerReport
Aldeyra Therapeutics $ALDX Earns Daily News Sentiment Rating of 0.17 https://t.co/nv0tz3s2Xh
November 14th 2017, 4:11pm
AmericanBanking @AmericanBanking
Aldeyra Therapeutics Gets Average Rating of Hold from Analysts $ALDX https://t.co/J7TKSc8CMW
November 14th 2017, 5:11am
Shark_Trades @Shark_Trades
Glad $aldx and $vnda came back to reality since this post
November 13th 2017, 10:11pm
bkfViking123 @bkfViking123
$aldx gap held ... watch list https://t.co/QTB5kVLzvU
November 12th 2017, 8:11am
dispatchtribune @dispatchtribune
Aldeyra Therapeutics, Inc. $ALDX Now Covered by Cantor Fitzgerald https://t.co/pLRJuEetj4
November 12th 2017, 6:11am
dispatchtribune @dispatchtribune
Aldeyra Therapeutics $ALDX versus The Competition Critical Survey https://t.co/SmTvm6EB6J
November 11th 2017, 7:11pm
dispatchtribune @dispatchtribune
Contrasting Aldeyra Therapeutics $ALDX and Epizyme $EPZM https://t.co/PgbWkTICoA
November 11th 2017, 11:11am
SPNewsAnalysis @SPNewsAnalysis
Aldeyra Therapeutics, Inc. $ALDX Posts Earnings Results, Beats Expectations By $0.09 EPS https://t.co/a5OqlfvgaZ
November 11th 2017, 9:11am
storminvestor @storminvestor
Aldeyra Therapeutics, Inc. $ALDX Posts Earnings Results, Beats Expectations By $0.09 EPS https://t.co/LsU8CNXa1u
November 11th 2017, 9:11am
ZolmaxNews @ZolmaxNews
Aldeyra Therapeutics, Inc. $ALDX Announces Quarterly Earnings Results https://t.co/icYiaFQOmh
November 10th 2017, 2:11pm
intercooleronli @intercooleronli
Aldeyra Therapeutics, Inc. $ALDX Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS https://t.co/0usKSD0s8C
November 10th 2017, 12:11pm
ConsumerFeed @ConsumerFeed
Aldeyra Therapeutics, Inc. $ALDX Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS https://t.co/oaYUmXPl6e #acn
November 10th 2017, 12:11pm
AmericanBanking @AmericanBanking
Aldeyra Therapeutics, Inc. $ALDX Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS https://t.co/jVvTGsRhOJ
November 10th 2017, 12:11pm
CFinancialNews @CFinancialNews
Aldeyra Therapeutics, Inc. $ALDX Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS https://t.co/fjFNtYPmT3
November 10th 2017, 12:11pm
ReadingMarkets @ReadingMarkets
Just bought $ALDX for 5.70. Hopefully, we are very close to support here.
November 9th 2017, 3:11pm
Ligand_LGND @Ligand_LGND
$ALDX announces that ADX-102 will now be called reproxalap https://t.co/0HUQ4QLooZ
November 9th 2017, 10:11am
tradingacess @tradingacess
$OTIC 60% inst. Ownership, they can pump this higher if they want and create a crazy squeeze, reminds me of $ALDX a few weeks ago ?
November 9th 2017, 10:11am
stocknewsdotcom @stocknewsdotcom
$ALDX Beats EPS loss estimates by $0.07 https://t.co/nHtOKC1ZXD
November 9th 2017, 8:11am
earningscast @earningscast
$ALDX Listen to Q3 2017 Aldeyra Therapeutics, Inc. Earnings Call live at 08:00 AM, ondemand after - https://t.co/WsVNhi0TAN
November 9th 2017, 7:11am
Traderideas1 @Traderideas1
RT @MarketCurrents: Aldeyra Therapeutics beats by $0.07 https://t.co/FqewSWIVQl #premarket $ALDX
November 9th 2017, 7:11am
Bigapple2la @Bigapple2la
If any of $ALDX's 2018 milestones works, it's at least a triple; if dry eye works it's a ten bagger. BIG IF...
November 9th 2017, 7:11am
StockTexts @StockTexts
$ALDX Aldeyra Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/15BDWT00xQ
November 9th 2017, 7:11am
wlstcom @wlstcom
Aldeyra Therapeutics beats by $0.07 #premarket #sitifatimah #malaysia #financialplanning #ALDX $ALDX #wlst https://t.co/yIkHCZx5Hd
November 9th 2017, 7:11am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Aldeyra Therapeutics beats by $0.07 https://t.co/1pXmQEHIPq #premarket $ALDX
November 9th 2017, 7:11am
MarketCurrents @MarketCurrents
Aldeyra Therapeutics beats by $0.07 https://t.co/FqewSWIVQl #premarket $ALDX
November 9th 2017, 7:11am
NASDAQODUK @NASDAQODUK
$ALDX Aldeyra Therapeutics to Present at the Stifel 2017 Healt… https://t.co/HXvYlazXGi
November 7th 2017, 11:11pm
hotpennyalerts @hotpennyalerts
$ALDX To Present at the Stifel 2017 Healthcare Conference https://t.co/cIfgDeRA8a
November 7th 2017, 8:11pm
WatchlistN @WatchlistN
Somewhat Positive Press Coverage Somewhat Unlikely to Affect Aldeyra Therapeutics $ALDX Share Price https://t.co/snvehWiPbA
November 7th 2017, 12:11pm
MarginHunt @MarginHunt
Multiple valuation analyses imply Aldeyra Therapeutics $ALDX is undervalued... earnings Thursday BMO https://t.co/yVk4Cofx2Q
November 7th 2017, 9:11am
StockNewsNow @StockNewsNow
$ALDX Aldeyra Therapeutics to Present at the Stifel 2017 Healthcare Conference https://t.co/W7IqiPJMlw
November 7th 2017, 9:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.